Eledon Pharmaceuticals

Organisation

Trials

  • NCT07835581

    Phase 3, Not yet recruiting, 620 people, 23 Sept 2026

  • NCT06972069

    Collaborator, Early phase 1, Active, not recruiting, 12 people, 14 May 2025

  • NCT06126380

    Phase 2, Enrolling by invitation, 132 people, 13 Nov 2023

  • NCT05983770

    Phase 2, Completed, 127 people, 9 Aug 2023

Named in competing interests

Sources: pubmed.ncbi.nlm.nih.gov